64631 Patient-Level Clinical Response Rates to GSK1070806, an Anti–IL-18 Monoclonal Antibody, in Moderate-to-Severe Atopic Dermatitis (AD): A Randomized, Double-Blind, Placebo-Controlled Study
2025 · Journal of the American Academy of Dermatology · 0 citations
https://doi.org/10.1016/j.jaad.2025.05.275